Concepedia

Heidi S. Feiler

HS

35

Publications

14.2K

Citations

29

H-Index

1987

Active since

Affiliations

University of California, San Francisco(Current)

Lawrence Berkeley National Laboratory

Oregon Health & Science University

Ernest Gallo Clinic and Research Center

University of North Carolina at Chapel Hill

Heidi S. Feiler is an author at University of California, San Francisco specializing in medicine, cell biology, and gene expression.

Top concepts

MedicineCell BiologyTumor BiologyGene ExpressionRadiation OncologyGeneticsOncologyBreast CancerCancer ResearchSystems Biology

Publications per year

1987–2022

35

Publications

35

Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1

Roel G.W. Verhaak, Katherine A. Hoadley, Elizabeth Purdom et al. · Cancer Cell · 2010 · 7.5K citations · Full text

Neuro-oncology, Oncology, Tumor Heterogeneity +13

Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy

Eric A. Collisson, Anguraj Sadanandam, Peter Olson et al. · Nature Medicine · 2011 · 1.9K citations · Full text

Pancreatic Cancer, Medicine, Pathology +7

Genomic and transcriptional aberrations linked to breast cancer pathophysiologies

Koei Chin, Sandy DeVries, Jane Fridlyand et al. · Cancer Cell · 2006 · 1.3K citations · Full text

Breast Oncology, Transcriptional Aberrations, Cancer Genomics +3

Subtype and pathway specific responses to anticancer compounds in breast cancer

Laura M. Heiser, Anguraj Sadanandam, Wen‐Lin Kuo et al. · Proceedings of the National Academy of Sciences · 2011 · 501 citations

Drug Target, Breast Oncology, Chemoprevention Strategy +17

Basal Subtype and MAPK/ERK Kinase (MEK)-Phosphoinositide 3-Kinase Feedback Signaling Determine Susceptibility of Breast Cancer Cells to MEK Inhibition

Olga K. Mirzoeva, Debopriya Das, Laura M. Heiser et al. · Cancer Research · 2009 · 386 citations · Full text

Rows per page

1–5 of 35